Winnergy Medical PCL (BKK:WINMED) Long-Term Debt: ฿88.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:WINMED Winnergy Medical PCL BKK:WINMED
76 GF Score
Price ฿1.22
GF Value ฿1.46
Valuation Modestly Undervalued
! 14 Warning Signs
View Full Analysis

What is Winnergy Medical PCL Long-Term Debt?

Winnergy Medical PCL BKK:WINMED +18.45% 76 Long-Term Debt is ฿88.9 Mil as of Jun. 2026. GuruFocus rates BKK:WINMED with a GF Score™ of 76/100 and a GF Value™ of ฿1.46 (Modestly Undervalued). The stock has 14 warning signs investors should review.

Winnergy Medical PCL's Long-Term Debt for the quarter that ended in Jun. 2026 was ฿88.9 Mil.

Winnergy Medical PCL's quarterly Long-Term Debt declined from Dec. 2025 (฿103.3 Mil) to Mar. 2026 (฿96.1 Mil) and declined from Mar. 2026 (฿96.1 Mil) to Jun. 2026 (฿88.9 Mil).

Winnergy Medical PCL's annual Long-Term Debt increased from Dec. 2023 (฿11.1 Mil) to Dec. 2024 (฿117.2 Mil) but then declined from Dec. 2024 (฿117.2 Mil) to Dec. 2025 (฿103.3 Mil).

Winnergy Medical PCL  (BKK:WINMED) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Winnergy Medical PCL Long-Term Debt Related Terms

Winnergy Medical PCL Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Winnergy Medical PCL's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Winnergy Medical PCL Long-Term Debt Chart

Winnergy Medical PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 24.44 11.11 117.16 103.28

Winnergy Medical PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110.99 104.16 103.28 96.06 88.85
BKK:WINMED
76GF Score
Winnergy Medical PCL BKK:WINMED
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ฿88.9 Mil mean?
Winnergy Medical PCL (BKK:WINMED) has a Long-Term Debt of ฿88.9 Mil as of Jun. 2026.
Is Winnergy Medical PCL's Long-Term Debt too high?
Winnergy Medical PCL's current Long-Term Debt is ฿88.9 Mil. Overall, Winnergy Medical PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Winnergy Medical PCL's Long-Term Debt compare to MCK and COR?
Winnergy Medical PCL's Long-Term Debt of ฿88.9 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Winnergy Medical PCL's current Long-Term Debt is ฿88.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winnergy Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Winnergy Medical PCL (BKK:WINMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.46, compared to a current price of ฿1.22 — trading 16.4% below its estimated fair value. The current Long-Term Debt is ฿88.9 Mil. Winnergy Medical PCL's overall GF Score™ is 76/100 with 14 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Winnergy Medical PCL (BKK:WINMED), the current Long-Term Debt is ฿88.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Winnergy Medical PCL (BKK:WINMED) Overvalued in 2026?

Based on GuruFocus' analysis, Winnergy Medical PCL stock appears to be undervalued. The current stock price of ฿1.22 is trading 16.4% below its estimated GF Value™ of ฿1.46. GuruFocus considers Winnergy Medical PCL to be Modestly Undervalued.

Key valuation signals for BKK:WINMED:

  • Long-Term Debt: ฿88.9 Mil
  • GF Value™: ฿1.46 vs. price of ฿1.22 (16.4% below fair value)
  • GF Score™: 76/100 with 14 warning signs

No single metric tells the full story. See the BKK:WINMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Winnergy Medical PCL Business Description

Address Pracha Uthit Road, No. 634/4 Soi Ramkhamhaeng 39 (Theplila 1), Wang Thong Lang Sub-District, Wang Thong Lang District, Bangkok, THA, 10310
Winnergy Medical PCL is engaged in the distribution of medical and diagnostics equipment. Its businesses include the distribution of medical devices, chemicals, and medical equipment and technology. The company operates in the geographic area of Thailand.
76GF Score

Get the complete analysis for BKK:WINMED

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.22
Price
฿1.46
GF Value